How do I subscribe to ongoing alerts?

Subscribe to /feed/company/instituto-nacional-de-ciencias-medicas-y-nutricion-salvador-zubiran.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran pipeline: 2 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
zidovudine + lamivudine + efavirenz	zidovudine + lamivudine + efavirenz	marketed	Antiretroviral combination therapy (NRTI + NNRTI)	HIV reverse transcriptase	Infectious Disease / Virology
zidovudine+lamivudine+lopinavir/ritonavir	zidovudine+lamivudine+lopinavir/ritonavir	marketed	Antiretroviral combination therapy (NRTI + PI)	HIV reverse transcriptase and HIV protease	Infectious Disease / Virology
Placebo (for Bezafibrate)	Placebo (for Bezafibrate)	phase 3			Cardiovascular

Therapeutic area mix

Infectious Disease / Virology · 2
Cardiovascular · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Hospital Clinic of Barcelona · 2 shared drug classes
Clinical Trial Agency of HIV Study Group · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
International Maternal Pediatric Adolescent AIDS Clinical Trials Group · 1 shared drug class
National Center for AIDS/STD Control and Prevention, China CDC · 1 shared drug class
Peking Union Medical College Hospital · 1 shared drug class
Sheba Medical Center · 1 shared drug class
Azienda Ospedaliera San Gerardo di Monza · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran:

Cite this brief

Drug Landscape (2026). Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/instituto-nacional-de-ciencias-medicas-y-nutricion-salvador-zubiran. Accessed 2026-05-17.